HTX-011 for Postoperative Pain Management Receives Breakthrough Therapy Designation from FDA 02/07/2018 Medications SAN DIEGO–(BUSINESS WIRE)–Jun. 21, 2018– Heron Therapeutics, Inc. (NASDAQ: HRTX), Read more